Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

India’s New Covid Cases Have Peaked, Cambridge Tracker Shows

Published 2021-05-12, 12:59 a/m
Updated 2021-05-12, 12:59 a/m
&copy Bloomberg. A health worker wearing prepares swab to be taken at a Covid-19 testing site set up in the employment exchange office in Agra, Uttar Pradesh, India, on Monday, May 3, 2021. India's fierce second wave has overwhelmed the nation's underfunded health system, with infections topping 400,000 cases in a day and hospitals running out of beds, oxygen and medical supplies.

(Bloomberg) -- The number of new coronavirus infections in India has peaked, according to a new tracker developed by researchers at Cambridge Judge Business School and the National Institute of Economic and Social Research.

“But there is substantial variation among states and union territories in their trajectories, with cases continuing to increase over the next two weeks in areas such as Assam, Himachal Pradesh, Tamil Nadu and Tripura,” the researchers wrote.

The projections are in line with those from some other experts, including Prime Minister Narendra Modi’s advisers.

Health services remain overwhelmed and several hospitals face shortage in oxygen supplies. The nation has reported more than 300,000 new infections for more than 20 straight days and the official tally of daily deaths has topped 4,000. The numbers are probably vastly undercounted, experts say.

©2021 Bloomberg L.P.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.